Equity ratings for Second Sight Medical Products are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting July 15, 2019 and ending today October 13, 2019. Click here to learn more.
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. The company was founded in 1998 and is headquartered in Sylmar, California. Second Sight operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 123 people. more
Second Sight Medical Products (EYES) is traded on BATS Exchange in USA. It is located in 12744 San Fernando Road and employs 123 people. Second Sight Medical Products was previously known as Second Sight Medical Products Inc Warrants and was traded on BATS Exchange under the symbol EYESW. Second Sight is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with current market capitalization of 115.24 M. Second Sight Medical conducts business under Healthcare sector and is part of Medical Devices industry. The entity has 124.59 M outstanding shares of which 4.7 M shares are currently shorted by private and institutional investors with about 32.84 trading days to cover.
Second Sight Medi currently holds about 25.16 M in cash with (28.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2.
Check Second Sight Probability Of Bankruptcy
Based on normal probability distribution, the odds of Second Sight to move above current price in 30 days from now is about 61.61 (This Second Sight Medical Products probability density function shows the probability of Second Sight Stock to fall within a particular range of prices over 30 days) .